SONM

Over the past six months, DNA X, Inc. (SONM) stock has been impacted by events related to its strategic transition. On November 25, 2025, Sonim Technologies filed a preliminary proxy statement, which saw the stock price decrease. On December 31, 2025, stockholders approved the asset sale to NEXA, resulting in a stock price increase. On January 26, 2026, NEXA completed the acquisition of Sonim's operating assets. On January 27, 2026, Sonim Technologies rebranded as DNA X, Inc., leading to a stock price increase. On April 14, 2026, DNA X, Inc. reported its Full Year 2025 Financial Results. On October 27, 2025, Stockholders approved and the board implemented a 1-for-18 reverse stock split. The stock price as of May 1, 2026, was $4.81 per share, a significant decline from $25.74 per share on May 5, 2025.